ALB and hypertensive disorder: On multivariate analysis, BCLC stage (HR 2.50 95% CI 1.40–4.45, p < 0.01), baseline albumin (HR 0.89, 95% CI 0.86–0.93, p < 0.01), the development of hypertension (HR 0.42, 95% CI 0.24–0.73, p < 0.01) or diarrhoea (HR 0.47, 95% CI 0.25–0.88, p = 0.01) and dose reduction (HR 0.41, 95% CI 0.24–0.69, p < 0.01) remained independent predictors for OS (Table 3).